LRRC32
Basic information
Region (hg38): 11:76657524-76670747
Previous symbols: [ "D11S833E", "GARP" ]
Links
Phenotypes
GenCC
Source:
- cleft palate, proliferative retinopathy, and developmental delay (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cleft palate, proliferative retinopathy, and developmental delay | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Craniofacial; Neurologic; Ophthalmologic | 30976112 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LRRC32 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 52 | 58 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 52 | 12 | 3 |
Variants in LRRC32
This is a list of pathogenic ClinVar variants found in the LRRC32 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-76657978-G-A | Benign (May 01, 2023) | |||
11-76659617-T-G | not specified | Uncertain significance (Feb 10, 2022) | ||
11-76659635-C-T | not specified | Uncertain significance (Jun 16, 2023) | ||
11-76659650-C-G | not specified | Uncertain significance (Apr 18, 2024) | ||
11-76659747-C-T | not specified | Uncertain significance (Apr 29, 2024) | ||
11-76659813-C-T | not specified | Uncertain significance (Mar 01, 2023) | ||
11-76659819-C-T | not specified | Uncertain significance (Jan 21, 2022) | ||
11-76659827-C-T | not specified | Uncertain significance (May 03, 2023) | ||
11-76659828-G-C | not specified | Uncertain significance (Apr 20, 2024) | ||
11-76659845-G-A | not specified | Uncertain significance (Mar 16, 2024) | ||
11-76659865-G-A | Likely benign (Apr 01, 2023) | |||
11-76659874-G-A | Likely benign (May 01, 2023) | |||
11-76659902-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
11-76659963-G-A | Global developmental delay;Vitreoretinopathy;Cleft palate • Cleft palate, proliferative retinopathy, and developmental delay | Pathogenic/Likely pathogenic (Oct 28, 2020) | ||
11-76660002-C-A | not specified | Uncertain significance (Jun 24, 2022) | ||
11-76660026-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
11-76660034-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
11-76660038-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
11-76660040-C-T | LRRC32-related disorder | Likely benign (May 04, 2023) | ||
11-76660042-C-A | not specified | Uncertain significance (Jun 05, 2023) | ||
11-76660079-A-T | not specified | Uncertain significance (May 11, 2022) | ||
11-76660081-C-A | not specified | Uncertain significance (Apr 25, 2023) | ||
11-76660083-T-C | not specified | Uncertain significance (Mar 20, 2023) | ||
11-76660089-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
11-76660092-T-C | not specified | Uncertain significance (May 08, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LRRC32 | protein_coding | protein_coding | ENST00000407242 | 2 | 13224 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00108 | 0.956 | 125732 | 0 | 16 | 125748 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0889 | 393 | 398 | 0.987 | 0.0000256 | 4202 |
Missense in Polyphen | 68 | 91.561 | 0.74267 | 1261 | ||
Synonymous | -1.17 | 210 | 190 | 1.11 | 0.0000117 | 1526 |
Loss of Function | 1.78 | 7 | 14.3 | 0.491 | 7.74e-7 | 148 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000371 | 0.000369 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000557 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000644 | 0.0000615 |
Middle Eastern | 0.0000557 | 0.0000544 |
South Asian | 0.0000657 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space (PubMed:19750484, PubMed:19651619, PubMed:22278742). Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta (PubMed:22278742). Able to outcompete LTBP1 for binding to LAP regulatory chain of TGF-beta (PubMed:22278742). Controls activation of TGF-beta-1 (TGFB1) on the surface of activated regulatory T-cells (Tregs) (PubMed:19750484, PubMed:19651619). Required for epithelial fusion during palate development by regulating activation of TGF-beta-3 (TGFB3) (By similarity). {ECO:0000250|UniProtKB:G3XA59, ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:22278742}.;
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- loftool
- 0.414
- rvis_EVS
- -1.21
- rvis_percentile_EVS
- 5.68
Haploinsufficiency Scores
- pHI
- 0.210
- hipred
- N
- hipred_score
- 0.234
- ghis
- 0.594
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.412
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lrrc32
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Zebrafish Information Network
- Gene name
- lrrc32
- Affected structure
- thrombocyte
- Phenotype tag
- abnormal
- Phenotype quality
- distributed
Gene ontology
- Biological process
- transforming growth factor beta receptor signaling pathway;positive regulation of gene expression;negative regulation of activated T cell proliferation;negative regulation of cytokine secretion;secondary palate development;regulation of transforming growth factor beta activation;regulation of transforming growth factor beta3 activation
- Cellular component
- extracellular space;nucleoplasm;integral component of plasma membrane;cell surface;extracellular matrix
- Molecular function
- protein binding;transforming growth factor beta binding